Oxurion
Emmanuèle Attout is a Non-Executive, Independent Director at Oxurion and a Co-founder and Executive Director of Women on Board Belgium. Emmanuèle has over 30 years of experience in the field of business, having worked as a partner at PwC for over 33 years. In 2014, they decided to leave PwC to pursue other opportunities. Emmanuèle has since then been working as a director at various companies, including Atenor, Schréder, and Eurocommercial Properties N.V.
Emmanuèle Attout is an international director who specializes in governance. Emmanuèle has a licence in applied economic sciences from Université catholique de Louvain and has also completed executive programmes in management and philosophy from Solvay Brussels School of Economics and Management and INSEAD. In addition, they have a degree from the Cambridge Institute for Sustainability Leadership in sustainable finance from the University of Cambridge. Emmanuèle has also completed an executive programme in Singapore on value creation for owners and directors from INSEAD.
This person is not in the org chart
This person is not in any offices
Oxurion
Oxurion (Euronext Brussels: OXUR - formerly known as ThromboGenics) is a biopharmaceutical company developing treatments to preserve vision in patients with diseases affecting the back of the eye. The company has built a diverse portfolio of disease-modifying therapies, including treatments for diabetic eye disease, a leading cause of blindness in people of working age worldwide.